Guardant Health (GH) Cash from Financing Activities (2017 - 2026)

Guardant Health has disclosed Cash from Financing Activities across 10 years of filings, most recently posting $23.0 million for Q2 2026.

• In Q2 2026, Cash from Financing Activities rose 1317.12% year-over-year to $23.0 million; the TTM figure through Jun 2026 stood at $737.8 million (up 1138.48% YoY), while the FY2025 annual figure was $671.1 million, up 67482.83% from the prior year.
• Cash from Financing Activities came in at $23.0 million for Q2 2026 at Guardant Health, up from -$21.6 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $732.0 million in Q4 2025 to a low of -$172.1 million in Q2 2022.
• Average Cash from Financing Activities over 5 years is $53.3 million, with a median of $806000.0 recorded in 2022.
• Year-over-year, Cash from Financing Activities tumbled 7016.67% in 2023 and soared 25041.33% in 2025.
• Over 5 years, Cash from Financing Activities stood at $2.3 million in 2022, then jumped by 3807.16% to $90.6 million in 2023, then plunged by 103.24% to -$2.9 million in 2024, then soared by 25041.33% to $732.0 million in 2025, then sank by 96.86% to $23.0 million in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were $23.0 million in Q2 2026, -$21.6 million in Q1 2026, and $732.0 million in Q4 2025.